← Back to headlines
Novo's woes in spite of Ozempic's growth
The market for weight-loss drugs is booming - but the pioneer in the field is shedding profits and share value, writes Adam Maguire
28 Feb, 07:00 — 28 Feb, 07:00
ℹOnly 1 source covers this story
